Page last updated: 2024-11-06

prednisolone and Preleukemia

prednisolone has been researched along with Preleukemia in 3 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Preleukemia: Conditions in which the abnormalities in the peripheral blood or bone marrow represent the early manifestations of acute leukemia, but in which the changes are not of sufficient magnitude or specificity to permit a diagnosis of acute leukemia by the usual clinical criteria.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bagby, GC1
Ost, A1
Lindström, P1
Christensson, B1
Gyllenhammar, H1
Engsted, L1
Hagiwara, S1
Yuo, A1
Miwa, A1
Takezako, N1
Hirano, N1
Togawa, A1

Other Studies

3 other studies available for prednisolone and Preleukemia

ArticleYear
Mechanisms of glucocorticosteroid activity in patients with the preleukemic syndrome (hemopoietic dysplasia).
    Leukemia research, 1980, Volume: 4, Issue:6

    Topics: Cells, Cultured; Colony-Forming Units Assay; Glucocorticoids; Granulocytes; Hematopoiesis; Humans; H

1980
Acute leukaemia in a defined geographic area--incidence, clinical history and prognosis.
    Scandinavian journal of haematology, 1984, Volume: 33, Issue:2

    Topics: Adolescent; Adult; Age Factors; Aged; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Lymphoid;

1984
A rare atypical myeloproliferative-disorder-like hemopathy with marked dysplasia, peripheral dominant myeloblast proliferation and extramedullary hematopoiesis was converted into typical acute myeloid leukemia with an interval of complete hematological re
    International journal of hematology, 1998, Volume: 67, Issue:4

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Daunorubicin

1998